MarketFoolery

The Lollipop War Has Begun

MarketFoolery

Biogen falls 30% after halting trials for its Alzheimerโ€™s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll.

Get $50 off your first job post at www.LinkedIn.com/Fool.

Next Episodes

MarketFoolery

FedEx, Brexit, and Leviโ€™s IPO @ MarketFoolery

๐Ÿ“† 2019-03-20 21:41 / โŒ› 00:21:57


MarketFoolery

The Challenges of Investing in Cannabis @ MarketFoolery

๐Ÿ“† 2019-03-19 19:31 / โŒ› 00:24:14


MarketFoolery

Uberโ€™s Foggy Future @ MarketFoolery

๐Ÿ“† 2019-03-18 17:24 / โŒ› 00:18:24


MarketFoolery

Bad Suits & Blazing Saddles @ MarketFoolery

๐Ÿ“† 2019-03-14 20:26 / โŒ› 00:21:38


MarketFoolery

2 Video Game Stocks We Like Right Now @ MarketFoolery

๐Ÿ“† 2019-03-13 21:42 / โŒ› 00:20:14